COVID (SARS-C0V-2 IgG/IgM) Antibody Testing

• validates COVID exposure, infection and Immune Response
• FDA-registered home-based, finger-stick test, results in 15 minutes
• both Early (IgM) and Late (IgG) antibodies
• applicable to ‘break-through’ Delta variant infections after vaccination failure
• defines onset of Natural Immunity following acute COVID infection